Insmed (Nasdaq:INSM) announced the closing today of its previously announced public offering of its 1.75% convertible senior notes due 2025. Insmed issued and sold in the public offering $450 million aggregate principal amount of its 1.75% convertible senior notes due 2025. As quoted in the press release: The net proceeds to Insmed from the offering …
Insmed (Nasdaq:INSM) announced the closing today of its previously announced public offering of its 1.75% convertible senior notes due 2025. Insmed issued and sold in the public offering $450 million aggregate principal amount of its 1.75% convertible senior notes due 2025.
As quoted in the press release:
The net proceeds to Insmed from the offering were approximately $435.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Insmed.
The Conversation (0)
Latest News
Outlook Reports world
Featured Pharmaceutical Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES